Clinical utility of urine pregnancy assays to determine medical abortion outcome is limited

Emily M. Godfrey, Anita Anderson, Stephen L. Fielding, Leslie Meyn, Mitchell D Creinin

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Background: Determining medical abortion outcome commonly includes a costly evaluation such as ultrasonography or serial serum hCG testing. Urine pregnancy testing may represent a less costly alternative. Methods: This prospective diagnostic test evaluation study was part of a multisite randomized trial of 1080 women undergoing medical abortion up to 63 days' gestation who returned 1 and 2 weeks after receiving mifepristone. Low-sensitivity (LS) and high-sensitivity (HS) urine pregnancy tests were performed at each visit, and the results were compared to ultrasonography. Sensitivity, specificity, predictive values and likelihood ratios of each urine test were determined. Results: In the first week following abortion, 14.8% of the LS tests and 7.9% of the HS tests correctly predicted outcome. None of the LS tests and only 0.2% of the HS tests were falsely negative; however, 85.2% of the LS tests and 91.8% of the HS tests were falsely positive. In the second week following abortion, 39.1% of the LS tests and 33.8% of the HS tests correctly predicted the medical abortion outcome. Only 0.2% of the LS tests and 0.3% of the HS were falsely negative; however, 60.8% of the LS tests and 65.8% of the HS tests were falsely positive. Conclusions: Both LS and HS urine pregnancy assays reliably assess clinical outcomes of medical abortions in cases of negative test results. However, the clinical utility of urine assay testing is limited because of the high rate of false-positive results.

Original languageEnglish (US)
Pages (from-to)378-382
Number of pages5
JournalContraception
Volume75
Issue number5
DOIs
StatePublished - May 2007
Externally publishedYes

Fingerprint

Urine
Pregnancy
Ultrasonography
Pregnancy Tests
Mifepristone
Routine Diagnostic Tests
Sensitivity and Specificity
Serum

Keywords

  • Likelihood ratio
  • Medical abortion
  • Mifepristone
  • Predictive value
  • Sensitivity
  • Specificity
  • Urine pregnancy test

ASJC Scopus subject areas

  • Medicine(all)
  • Obstetrics and Gynecology

Cite this

Clinical utility of urine pregnancy assays to determine medical abortion outcome is limited. / Godfrey, Emily M.; Anderson, Anita; Fielding, Stephen L.; Meyn, Leslie; Creinin, Mitchell D.

In: Contraception, Vol. 75, No. 5, 05.2007, p. 378-382.

Research output: Contribution to journalArticle

Godfrey, Emily M. ; Anderson, Anita ; Fielding, Stephen L. ; Meyn, Leslie ; Creinin, Mitchell D. / Clinical utility of urine pregnancy assays to determine medical abortion outcome is limited. In: Contraception. 2007 ; Vol. 75, No. 5. pp. 378-382.
@article{31f0f4fecd09470ea03c7871d933167a,
title = "Clinical utility of urine pregnancy assays to determine medical abortion outcome is limited",
abstract = "Background: Determining medical abortion outcome commonly includes a costly evaluation such as ultrasonography or serial serum hCG testing. Urine pregnancy testing may represent a less costly alternative. Methods: This prospective diagnostic test evaluation study was part of a multisite randomized trial of 1080 women undergoing medical abortion up to 63 days' gestation who returned 1 and 2 weeks after receiving mifepristone. Low-sensitivity (LS) and high-sensitivity (HS) urine pregnancy tests were performed at each visit, and the results were compared to ultrasonography. Sensitivity, specificity, predictive values and likelihood ratios of each urine test were determined. Results: In the first week following abortion, 14.8{\%} of the LS tests and 7.9{\%} of the HS tests correctly predicted outcome. None of the LS tests and only 0.2{\%} of the HS tests were falsely negative; however, 85.2{\%} of the LS tests and 91.8{\%} of the HS tests were falsely positive. In the second week following abortion, 39.1{\%} of the LS tests and 33.8{\%} of the HS tests correctly predicted the medical abortion outcome. Only 0.2{\%} of the LS tests and 0.3{\%} of the HS were falsely negative; however, 60.8{\%} of the LS tests and 65.8{\%} of the HS tests were falsely positive. Conclusions: Both LS and HS urine pregnancy assays reliably assess clinical outcomes of medical abortions in cases of negative test results. However, the clinical utility of urine assay testing is limited because of the high rate of false-positive results.",
keywords = "Likelihood ratio, Medical abortion, Mifepristone, Predictive value, Sensitivity, Specificity, Urine pregnancy test",
author = "Godfrey, {Emily M.} and Anita Anderson and Fielding, {Stephen L.} and Leslie Meyn and Creinin, {Mitchell D}",
year = "2007",
month = "5",
doi = "10.1016/j.contraception.2007.01.021",
language = "English (US)",
volume = "75",
pages = "378--382",
journal = "Contraception",
issn = "0010-7824",
publisher = "Elsevier USA",
number = "5",

}

TY - JOUR

T1 - Clinical utility of urine pregnancy assays to determine medical abortion outcome is limited

AU - Godfrey, Emily M.

AU - Anderson, Anita

AU - Fielding, Stephen L.

AU - Meyn, Leslie

AU - Creinin, Mitchell D

PY - 2007/5

Y1 - 2007/5

N2 - Background: Determining medical abortion outcome commonly includes a costly evaluation such as ultrasonography or serial serum hCG testing. Urine pregnancy testing may represent a less costly alternative. Methods: This prospective diagnostic test evaluation study was part of a multisite randomized trial of 1080 women undergoing medical abortion up to 63 days' gestation who returned 1 and 2 weeks after receiving mifepristone. Low-sensitivity (LS) and high-sensitivity (HS) urine pregnancy tests were performed at each visit, and the results were compared to ultrasonography. Sensitivity, specificity, predictive values and likelihood ratios of each urine test were determined. Results: In the first week following abortion, 14.8% of the LS tests and 7.9% of the HS tests correctly predicted outcome. None of the LS tests and only 0.2% of the HS tests were falsely negative; however, 85.2% of the LS tests and 91.8% of the HS tests were falsely positive. In the second week following abortion, 39.1% of the LS tests and 33.8% of the HS tests correctly predicted the medical abortion outcome. Only 0.2% of the LS tests and 0.3% of the HS were falsely negative; however, 60.8% of the LS tests and 65.8% of the HS tests were falsely positive. Conclusions: Both LS and HS urine pregnancy assays reliably assess clinical outcomes of medical abortions in cases of negative test results. However, the clinical utility of urine assay testing is limited because of the high rate of false-positive results.

AB - Background: Determining medical abortion outcome commonly includes a costly evaluation such as ultrasonography or serial serum hCG testing. Urine pregnancy testing may represent a less costly alternative. Methods: This prospective diagnostic test evaluation study was part of a multisite randomized trial of 1080 women undergoing medical abortion up to 63 days' gestation who returned 1 and 2 weeks after receiving mifepristone. Low-sensitivity (LS) and high-sensitivity (HS) urine pregnancy tests were performed at each visit, and the results were compared to ultrasonography. Sensitivity, specificity, predictive values and likelihood ratios of each urine test were determined. Results: In the first week following abortion, 14.8% of the LS tests and 7.9% of the HS tests correctly predicted outcome. None of the LS tests and only 0.2% of the HS tests were falsely negative; however, 85.2% of the LS tests and 91.8% of the HS tests were falsely positive. In the second week following abortion, 39.1% of the LS tests and 33.8% of the HS tests correctly predicted the medical abortion outcome. Only 0.2% of the LS tests and 0.3% of the HS were falsely negative; however, 60.8% of the LS tests and 65.8% of the HS tests were falsely positive. Conclusions: Both LS and HS urine pregnancy assays reliably assess clinical outcomes of medical abortions in cases of negative test results. However, the clinical utility of urine assay testing is limited because of the high rate of false-positive results.

KW - Likelihood ratio

KW - Medical abortion

KW - Mifepristone

KW - Predictive value

KW - Sensitivity

KW - Specificity

KW - Urine pregnancy test

UR - http://www.scopus.com/inward/record.url?scp=34047255922&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34047255922&partnerID=8YFLogxK

U2 - 10.1016/j.contraception.2007.01.021

DO - 10.1016/j.contraception.2007.01.021

M3 - Article

C2 - 17434020

AN - SCOPUS:34047255922

VL - 75

SP - 378

EP - 382

JO - Contraception

JF - Contraception

SN - 0010-7824

IS - 5

ER -